Genomics

Dataset Information

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to ER-directed therapies


ABSTRACT: Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to ER-directed therapies

PROVIDER: PRJNA497449 | ENA |

REPOSITORIES: ENA